Literature DB >> 2570792

Mannose-resistant hemagglutination, enzyme-linked immunosorbent assay, and immune electron microscopy for detection of K99 fimbrial antigen in Escherichia coli from calves.

F Hernández1, M Caballero, P Rivera, D Hird.   

Abstract

Mannose-resistant hemagglutination (MRHA) was evaluated for identification of Escherichia coli with K99 fimbriae. The sensitivity and specificity of MRHA, relative to the enzyme-linked immunosorbent assay, were 21 and 79%, respectively. Disagreement between the tests may have been due in part to separation of pili from the cells, with resultant enzyme-linked immunosorbent assay-positive, MRHA-negative tests. MRHA was not useful as the sole means for the identification of E. coli with K99 fimbriae.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2570792      PMCID： PMC267755          DOI： 10.1128/jcm.27.9.2123-2124.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

1.  Homogeneous distribution of parainfluenza virus glycoproteins demonstrated by immunogold-labelling and light staining with uranyl acetate in electron microscopy.

Authors:  F Hernandez; P Rivera; Y Hosaka
Journal:  J Virol Methods       Date:  1987-03       Impact factor: 2.014

2.  Improved minca medium for the detection of K99 antigen in calf enterotoxigenic strains of Escherichia coli.

Authors:  P A Guinée; J Veldkamp; W H Jansen
Journal:  Infect Immun       Date:  1977-02       Impact factor: 3.441

Review 3.  The structure, function, synthesis and genetic control of bacterial pili and a molecular model for DNA and RNA transport in gram negative bacteria.

Authors:  C C Brinton
Journal:  Trans N Y Acad Sci       Date:  1965-06

Review 4.  Host-specific fimbrial adhesins of noninvasive enterotoxigenic Escherichia coli strains.

Authors:  W Gaastra; F K de Graaf
Journal:  Microbiol Rev       Date:  1982-06

5.  Monoclonal antibody enzyme-linked immunosorbent assay for identification of K99-positive Escherichia coli isolates from calves.

Authors:  K W Mills; K L Tietze
Journal:  J Clin Microbiol       Date:  1984-04       Impact factor: 5.948

6.  Monoclonal antibody passive hemagglutination and capture enzyme-linked immunosorbent assays for direct detection and quantitation of F41 and K99 fimbrial antigens in enterotoxigenic Escherichia coli.

Authors:  T J Raybould; C F Crouch; S D Acres
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

7.  Hemagglutination of human group A erythrocytes by enterotoxigenic Escherichia coli isolated from adults with diarrhea: correlation with colonization factor.

Authors:  D G Evans; D J Evans; W Tjoa
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

8.  Mannose-resistant haemagglutination and P antigen recognition are characteristic of Escherichia coli causing primary pyelonephritis.

Authors:  V Väisänen; J Elo; L G Tallgren; A Siitonen; P H Mäkelä; C Svanborg-Edén; G Källenius; S B Svenson; H Hultberg; T Korhonen
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

Review 9.  Escherichia coli that cause diarrhea: enterotoxigenic, enteropathogenic, enteroinvasive, enterohemorrhagic, and enteroadherent.

Authors:  M M Levine
Journal:  J Infect Dis       Date:  1987-03       Impact factor: 5.226
  9 in total
  2 in total

1.  A single-chain fragment variable recombinant antibody against F5 fimbria of enterotoxigenic Escherichia coli inhibits agglutination of horse red blood cells induced by F5 protein.

Authors:  S Bhaskaran; C M Jay; L R Berghman; G G Wagner; S D Waghela
Journal:  Vet Res Commun       Date:  2005-08       Impact factor: 2.459

2.  Reduction of enterotoxin induced fluid accumulation in ileal loops of neonatal calves with anti-F5 fimbriae recombinant antibody.

Authors:  Alfredo Sahagun-Ruiz; Leticia V Velazquez; Shoba Bhaskaran; Chris M Jay; E Morales-Salinas; Keerti Rathore; Gale G Wagner; Suryakant D Waghela
Journal:  Vet Res Commun       Date:  2015-10-31       Impact factor: 2.459
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.